• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Ex-CEO Michael Pearson sues Valeant over unpaid shares

    Ex-CEO Michael Pearson sues Valeant over unpaid shares

  2. Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock

    Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock

  3. Valeant CEO Joseph Papa made $62.7 million last year

    Valeant CEO Joseph Papa made $62.7 million last year

  4. Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 4th Update

    Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 4th Update

  5. Valeant Paid CEO $62.7 Million Total -- WSJ

    Valeant Paid CEO $62.7 Million Total -- WSJ

  6. Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 3rd Update

    Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 3rd Update

  7. News Highlights: Top Company News of the Day

    News Highlights: Top Company News of the Day

  8. UPDATE: Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

    UPDATE: Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

  9. Antifungal Drugs: $16.1 Billion Technologies and Global Markets Report 2017-2021 - Research and Markets

    Antifungal Drugs: $16.1 Billion Technologies and Global Markets Report 2017-2021 - Research and Markets

  10. William Ackman's Valeant Loss Is Short-Sellers' Gain -- WSJ

    William Ackman's Valeant Loss Is Short-Sellers' Gain -- WSJ

12345

©2017 Morningstar Advisor. All right reserved.